Molecular epidemiology of malaria in Cameroon. XI. Geographic distribution of Plasmodium falciparum isolates with dihydrofolate reductase gene mutations in southern and central Cameroon

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 4, 2002, Pages 378-382

  Basco, Leonardo K ^a   Ndounga, Mathieu ^a   Tejiokem, Mathurin ^a   Foumane Ngane, Vincent ^a   Youmba, Jean Christian ^a   Ringwald, Pascal ^a   Soula, Georges ^a  

^a Institut de Recherche pour le Developpement Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; MOLECULAR MARKER; PYRIMETHAMINE;

ARTICLE; CAMEROON; CITY; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; WILD TYPE;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036807787     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.378     Document Type: Article

References (18)

1. Fidock DA, Su XZ, Deitsch KW, Wellems TE, 1999. Genetic approaches to the determinants of drug response, pathogenesis, and infectivity in Plasmodium falciparum malaria. Wahlgren M, Perlmann P, eds. Malaria: Molecular and Clinical Aspects. Amsterdam: Harwood Academic Publishers, 217-248.
2. McCutchan TF, Welsh JA, Dame JB, Quakyi IA, Graves PM, Drake JC, Allegra CJ, 1984. Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum. Antimicrob Agents Chemother 26: 656-659.
3. Zolg JW, Plitt JR, Chen GX, Palmer S, 1989. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethalmine resistance in Plasmodium falciparum. Mol Biochem Parasitol 36: 253-262.
4. Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV, 1997. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA 94: 1124-1129.
5. Hyde JE, 1990. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacol Ther 48: 45-59.
6. Basco LK, Eldin de Pécoulas P, Wilson CM, Le Bras J, Mazabraud A, 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
7. Reeder JC, Rieckmann KH, Genton B, Lorry K, Wines B, Cowman AF, 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am J Trop Med Hyg 55: 209-213.
8. Basco LK, Ringwald P, 2000. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am J Trop Med Hyg 62: 271-276.
9. Brobey RKB, Sano G, Itoh F, Aso K, Kimura M, Mitamura T, Horii T, 1996. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials. Mol Biochem Parasitol 81: 225-237.
10. Wu YM, Kirkman LA, Wellems TE, 1996. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci USA 93: 1130-1134.
11. Foote SJ, Galatas D, Cowman AF, 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87: 3014-3017.
12. Peterson DS, Milhous WK, Wellems TE, 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87: 3018-3022.
13. Basco LK, Tahar R, Keundjian A, Ringwald P, 2000. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. J Infect Dis 182: 624-628.
14. Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, Watkins WM, 2000. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: Genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother 44: 991-996.
15. World Health Organization, 1996. Assessment of Therapeutic Efficacy for Uncomplicated Falciparum Malaria in Areas With Intense Transmission. Geneva: World Health Organization. WHO/MAL/96.1077.
16. Long GW, Fries L, Watt GH, Hoffman SL, 1995. Polymerase chain reaction amplification from Plasmodium falciparum on dried blood spots. Am J Trop Med Hyg 52: 344-346.
17. Henning L, Felger I, Beck HP, 1999. Rapid DNA extraction for molecular epidemiological studies of malaria. Acta Trop 72: 149-155.
18. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN, 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61: 315-320.